Monte Rosa Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jul '26 Jul 10, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,946	1,028	427	283	375	950
Market Cap Growth	563.39%	140.76%	50.68%	-24.53%	-60.50%	-
Enterprise Value	1,319	689.81	97.43	96.92	159.53	604.19
Last Close Price	23.04	15.68	6.94	5.65	7.61	20.42
PS Ratio	45.31	8.31	5.64	-	-	-
PB Ratio	3.72	4.41	1.91	1.58	1.38	2.73
P/TBV Ratio	3.84	5.59	2.30	1.62	1.32	1.47
P/FCF Ratio	-	-	11.23	-	-	-
P/OCF Ratio	-	-	10.16	-	-	-
EV/Sales Ratio	30.71	5.58	1.29	-	-	-
EV/FCF Ratio	-	-	2.56	-	-	-
Debt / Equity Ratio	0.07	0.15	0.17	0.24	0.16	0
Debt / FCF Ratio	-	-	1.12	-	-	-
Net Debt / Equity Ratio	-1.20	-1.45	-1.48	-1.04	-0.79	-1.00
Net Debt / EBITDA Ratio	4.48	7.37	4.51	1.36	1.99	4.89
Net Debt / FCF Ratio	31.91	12.29	-8.67	2.97	2.05	5.01
Asset Turnover	0.07	0.28	0.20	0	0	0
Quick Ratio	9.44	6.05	2.37	5.00	10.58	20.80
Current Ratio	9.54	6.12	2.40	5.07	10.79	20.96
Return on Equity (ROE)	-34.44%	-16.94%	-36.15%	-60.07%	-35.06%	-40.35%
Return on Assets (ROA)	-24.67%	-11.88%	-22.65%	-44.47%	-31.71%	-35.06%
Return on Invested Capital (ROIC)	-	-	-	-592.89%	-394.11%	-
Return on Capital Employed (ROCE)	-28.25%	-16.27%	-30.10%	-49.94%	-33.72%	-39.42%
FCF Yield	-	-	8.90%	-	-	-
Buyback Yield / Dilution	-9.92%	-12.40%	-43.80%	-8.83%	-88.91%	-1548.09%
Total Shareholder Return	-9.92%	-12.40%	-43.80%	-8.83%	-88.91%	-1548.09%

SEC Filings: 10-K · 10-Q